Literature DB >> 28646475

Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.

G Sapuppo1, F Palermo2, M Russo3, M Tavarelli1, R Masucci4, S Squatrito1, R Vigneri1,5,6, G Pellegriti7.   

Abstract

PURPOSE: Papillary thyroid carcinoma (PTC), the most common thyroid cancer histotype, has a good prognosis even when spread to the neck lymph node (LN). The prognostic role of LN metastases' location is still controversial. The aim of the present study was to evaluate the clinical relevance of the number and location of LN metastases at presentation in PTCs.
METHODS: This retrospective study included a consecutive series of 1653 PTC patients followed for a mean period of 5.9 years in a referral thyroid cancer clinic. All patients have undergone thyroidectomy with the dissection of at least six LNs. According to the LN status, patients were subdivided into 569 N0 (34.4%), 644 N1a (39.0%, central compartment) and 440 N1b (26.6%, latero-cervical compartment).
RESULTS: Age at diagnosis was significantly lower in N1b (39.8, IQR 30.7-51.6) and N1a (40.1, IQR 31.3-50.1) than in N0 (44.7, IQR 36.6-55.0 yrs). The male gender was more prevalent in N1b than in N1a and N0 (F/M = 1.9/1, 4.0/1 and 5.5/1, respectively). Persistent/recurrent disease at last control was significantly more frequent in N1b (29.8%) than in N1a (14.3%), and in N1a than in N0 (4.2%) (p < 0.01 for all). Also, distant metastases were significantly (p < 0.001) more frequent in N1b (14.1%) than in N1a (4.3%) and N0 (1.6%). LN metastases' number (>5) was a significant risk factor for persistent/recurrent disease only for N1a patients.
CONCLUSIONS: These data indicate that persistent/recurrent disease and distant metastases are significantly more frequent in patients with latero-cervical LN (N1b) metastases and that the LN location should be used for a better postsurgical risk stratification.

Entities:  

Keywords:  Latero-cervical lymph node metastases; Papillary thyroid cancer; Thyroid cancer; Thyroid cancer metastases; Thyroid cancer outcome

Mesh:

Year:  2017        PMID: 28646475     DOI: 10.1007/s40618-017-0714-y

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  43 in total

1.  General and statistical hierarchy of appropriate biologic endpoints.

Authors:  Daniel Sargent
Journal:  Oncology (Williston Park)       Date:  2006-05       Impact factor: 2.990

Review 2.  Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients.

Authors:  M G Castagna; S Cantara; F Pacini
Journal:  J Endocrinol Invest       Date:  2016-06-27       Impact factor: 4.256

3.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.

Authors:  Erik K Alexander; Giulia C Kennedy; Zubair W Baloch; Edmund S Cibas; Darya Chudova; James Diggans; Lyssa Friedman; Richard T Kloos; Virginia A LiVolsi; Susan J Mandel; Stephen S Raab; Juan Rosai; David L Steward; P Sean Walsh; Jonathan I Wilde; Martha A Zeiger; Richard B Lanman; Bryan R Haugen
Journal:  N Engl J Med       Date:  2012-06-25       Impact factor: 91.245

4.  Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.

Authors:  John M Stulak; Clive S Grant; David R Farley; Geoffrey B Thompson; Jon A van Heerden; Ian D Hay; Carl C Reading; J William Charboneau
Journal:  Arch Surg       Date:  2006-05

5.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

6.  Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography.

Authors:  Iwao Sugitani; Yoshihide Fujimoto; Keiko Yamada; Noriko Yamamoto
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

Review 7.  Thyroid cancer nodal metastases: biologic significance and therapeutic considerations.

Authors:  S K Grebe; I D Hay
Journal:  Surg Oncol Clin N Am       Date:  1996-01       Impact factor: 3.495

8.  Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

Authors:  Armando Bartolazzi; Fabio Orlandi; Enrico Saggiorato; Marco Volante; Federico Arecco; Ruth Rossetto; Nicola Palestini; Ezio Ghigo; Mauro Papotti; Gianni Bussolati; Marco Paolo Martegani; Federico Pantellini; Angelo Carpi; Maria Rosaria Giovagnoli; Salvatore Monti; Vincenzo Toscano; Salvatore Sciacchitano; Gian Maria Pennelli; Caterina Mian; Maria Rosa Pelizzo; Massimo Rugge; Giancarlo Troncone; Lucio Palombini; Gennaro Chiappetta; Gerardo Botti; Aldo Vecchione; Rino Bellocco
Journal:  Lancet Oncol       Date:  2008-05-19       Impact factor: 41.316

9.  Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence.

Authors:  Jeonghun Lee; Youngpeck Song; Euy Young Soh
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

10.  Metastatic Lymph Node Ratio of Central Neck Compartment Has Predictive Values for Locoregional Recurrence in Papillary Thyroid Microcarcinoma.

Authors:  Sung Yong Choi; Jae-Keun Cho; Jeong Hwan Moon; Young-Ik Son
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-03-07       Impact factor: 3.372

View more
  15 in total

1.  Lymph node location is a risk factor for papillary thyroid cancer-related death.

Authors:  G Sapuppo; M Tavarelli; M Russo; P Malandrino; A Belfiore; R Vigneri; G Pellegriti
Journal:  J Endocrinol Invest       Date:  2018-03-16       Impact factor: 4.256

2.  Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine.

Authors:  P W Rosario; G Mourão; M R Calsolari
Journal:  J Endocrinol Invest       Date:  2018-10-23       Impact factor: 4.256

3.  Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Q A Yu; D K Ma; K P Liu; P Wang; C M Xie; Y H Wu; W J Dai; H C Jiang
Journal:  J Endocrinol Invest       Date:  2018-03-17       Impact factor: 4.256

4.  Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma.

Authors:  Jiang Zhu; Rui Huang; Ping Yu; Daixing Hu; Haoyu Ren; Chun Huang; Xinliang Su
Journal:  Gland Surg       Date:  2021-01

5.  Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.

Authors:  Y Luo; Y Zhao; K Chen; J Shen; J Shi; S Lu; J Lei; Z Li; D Luo
Journal:  J Endocrinol Invest       Date:  2018-06-06       Impact factor: 4.256

6.  Disease-free Survival of Patients with Differentiated Thyroid Cancer: A Study from a Tertiary Center in Oman.

Authors:  Fathimabeebi P Kunjumohamed; Abdulhakeem Al Rawahi; Noor B Al Busaidi; Hilal N Al Musalhi
Journal:  Oman Med J       Date:  2021-03-31

7.  Clinical Analysis of Cervical Lymph Node Metastasis Risk Factors and the Feasibility of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma.

Authors:  Yifan Chen; Shuo Chen; Xiaoying Lin; Xiangqing Huang; Xiaofang Yu; Juying Chen
Journal:  Int J Endocrinol       Date:  2021-01-31       Impact factor: 3.257

8.  Effectiveness of Lymphatic Contrast Enhanced Ultrasound in the diagnosis of Cervical Lymph node metastasis from papillary thyroid carcinoma.

Authors:  Ying Wei; Yun Niu; Zhen-Long Zhao; Xiao-Jing Cao; Li-Li Peng; Yan Li; Ming-An Yu
Journal:  Sci Rep       Date:  2022-01-12       Impact factor: 4.379

9.  Machine Learning and Feature Selection Applied to SEER Data to Reliably Assess Thyroid Cancer Prognosis.

Authors:  Moustafa Mourad; Sami Moubayed; Aaron Dezube; Youssef Mourad; Kyle Park; Albertina Torreblanca-Zanca; José S Torrecilla; John C Cancilla; Jiwu Wang
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

10.  Risk Factors and Prediction Model for Lateral Lymph Node Metastasis of Papillary Thyroid Carcinoma in Children and Adolescents.

Authors:  Weili Liang; Lei Sheng; Liguang Zhou; Changyuan Ding; Zhongyang Yao; Chao Gao; Qingdong Zeng; Bo Chen
Journal:  Cancer Manag Res       Date:  2021-02-16       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.